44.62
前日終値:
$44.92
開ける:
$45
24時間の取引高:
18.43M
Relative Volume:
0.90
時価総額:
$64.66B
収益:
$20.62B
当期純損益:
$3.56B
株価収益率:
18.71
EPS:
2.3847
ネットキャッシュフロー:
$3.48B
1週間 パフォーマンス:
+1.62%
1か月 パフォーマンス:
-11.42%
6か月 パフォーマンス:
-35.84%
1年 パフォーマンス:
-54.32%
Boston Scientific Corp Stock (BSX) Company Profile
名前
Boston Scientific Corp
セクター
電話
508-683-4000
住所
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, MDT, SYK, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
BSX
Boston Scientific Corp
|
44.62 | 64.66B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
ABT
Abbott Laboratories
|
103.49 | 179.08B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
89.30 | 114.23B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
273.40 | 104.87B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
EW
Edwards Lifesciences Corp
|
86.82 | 50.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-30 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | ダウングレード | Erste Group | Buy → Hold |
| 2025-09-08 | アップグレード | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 開始されました | Leerink Partners | Outperform |
| 2025-04-16 | アップグレード | Needham | Hold → Buy |
| 2025-01-10 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-10-18 | ダウングレード | Needham | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2024-02-01 | アップグレード | Mizuho | Neutral → Buy |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-06-30 | 開始されました | CL King | Buy |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2022-12-22 | 開始されました | Mizuho | Neutral |
| 2022-12-20 | 再開されました | Citigroup | Buy |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-06 | 開始されました | Wolfe Research | Outperform |
| 2022-05-27 | アップグレード | Needham | Hold → Buy |
| 2022-04-13 | 再開されました | Truist | Buy |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-05-26 | ダウングレード | Needham | Buy → Hold |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-17 | 開始されました | Truist | Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
| 2020-04-22 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | アップグレード | Goldman | Neutral → Buy |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Neutral |
| 2020-02-06 | 再開されました | BTIG Research | Buy |
| 2019-12-30 | 繰り返されました | Cowen | Outperform |
| 2019-12-19 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-09-05 | 再開されました | JP Morgan | Overweight |
| 2019-09-03 | 再開されました | Barclays | Overweight |
| 2019-05-13 | アップグレード | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 開始されました | UBS | Buy |
| 2018-10-16 | 開始されました | Barclays | Overweight |
| 2018-10-02 | 繰り返されました | Morgan Stanley | Overweight |
| 2018-09-07 | 繰り返されました | Needham | Strong Buy |
| 2018-09-04 | アップグレード | Jefferies | Hold → Buy |
| 2018-07-06 | 繰り返されました | Needham | Strong Buy |
| 2018-06-27 | 開始されました | Bernstein | Outperform |
| 2018-04-26 | 繰り返されました | Needham | Strong Buy |
すべてを表示
Boston Scientific Corp (BSX) 最新ニュース
Mexico Cardiac Rhythm Management Devices Market Outlook to 2036 Provides Revenue, Volume, Pricing and Competitive Insig - GlobeNewswire Inc.
Wells Fargo Adjusts Price Target on Boston Scientific to $48 From $50, Keeps Equalweight Rating - marketscreener.com
Boston Scientific stock slips before the bell after September 23 decline - AD HOC NEWS
Boston Scientific (BSX) Executive VP Arthur C. Butcher to Retire in January 2027 - GuruFocus
Boston Scientific Corporation Announces Retirement of Arthur C. Butcher from Executive Vice President and Group President, Medsurg and Asia Pacific, Effective January 1, 2027 - marketscreener.com
Boston Scientific announces retirement of executive vice president Arthur C. Butcher - Investing.com
Form 8K Boston Scientific Corp For: 23 September By Investing.com - Investing.com Canada
Form 8K Boston Scientific Corp For: 23 September - Investing.com India
Arthur C. Butcher to Retire as Executive VP & Group President at Boston Scientific - TradingView
Boston Scientific stock advances 2.1 percent ahead of the open - AD HOC NEWS
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific re-evaluates 2027 framework after cyberattack - scanx.trade
Boston Scientific stock holds near its yearly low after downgrade - AD HOC NEWS
What Boston Scientific (BSX) Tells Us About the Healthcare Stocks Trade Right Now - Kalkine Media
Boston Scientific stock heads into the open after a 0.9% gain - AD HOC NEWS
Boston Scientific stock holds steady as Oppenheimer cuts price target to USD 65 - AD HOC NEWS
Oppenheimer Adjusts Price Target on Boston Scientific to $65 From $85, Maintains Outperform Rating - marketscreener.com
Boston Scientific stock holds steady as analysts weigh cyberattack impact - AD HOC NEWS
Citi downgrades Boston Scientific as cyberattack recovery compounds competitive pressure - MassDevice
Boston Scientific Shares Fall After Citigroup Downgrade - marketscreener.com
Citi downgrades Boston Scientific on uncertain recovery path - Investing.com
Boston Scientific Can't Dislodge Rival's Heart Valve Patent - law360.com
TD Cowen maintains Boston Scientific stock rating after cyberattack - Investing.com
Citigroup Downgrades Boston Scientific to Neutral From Buy, Adjusts PT to $50 From $57 - marketscreener.com
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Boston Scientific: A Great Company At A Deeply Discounted Price (Rating Upgrade) - Seeking Alpha
Here’s How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years - Benzinga
Boston Scientific Corp Share PriceBSX, RNS News, Articles, Quotes, & Charts (NYSE:BSX) - Proactive financial news
Boston Scientific (BSX) Didn’t Miss on Demand or Devices. A Cyberattack Just Broke Its Guidance. - Yahoo Finance
Why Did BSX Cut FY26 Guidance? CEO Details Three Unanticipated Factors At Bernstein Conference - Stocktwits
Boston Scientific stock falls as cyberattack clouds 2026 outlook - ad-hoc-news.de
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance
Boston Scientific fully restores operations after cyberattack - Yahoo Finance
What Is Moving the Story Around Boston Scientific (BSX)? - Kalkine Media
Why Boston Scientific (BSX) Dipped More Than Broader Market Today - Yahoo Finance
Boston Scientific Corp (BSX) Stock Down 4.1% -- Now Undervalued? GF Score: 77/100 - GuruFocus
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Alpha Buying: 4 Falling Knives Insiders Are Buying - Benzinga
Boston Scientific stock falls as cyberattack clouds 2026 guidance - ad-hoc-news.de
Boston Scientific at Wells Fargo conference: cyberattack clouds outlook By Investing.com - Investing.com India
Boston Scientific at Wells Fargo conference: cyberattack clouds outlook - Investing.com
Boston Scientific Corp at Wells Fargo Healthcare Conference Transcript - GuruFocus
Update on recent cybersecurity incident - Boston Scientific
Boston Scientific stock falls as cyberattack prompts guidance cut and BTIG lowers price target - ad-hoc-news.de
Boston Scientific Flags Financial Hit From Cyberattack - BankInfoSecurity
Imax To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
BSX Maintains Buy Rating by BTIG -- Price Target Lowered to $56 - GuruFocus
Boston Scientific Corp. Stock Slides 5.9%, Underperforms Peers - webull.com
Boston Scientific says cyberattack likely to hurt 2026 sales, profit By Reuters - investing.com
Boston Scientific Corp (BSX) Stock Down 5.9% -- Now Undervalued? GF Score: 77/100 - GuruFocus
Boston Scientific says unlikely to meet 2026 sales, profit forecast after cyberattack - theinsurer.com
Boston Scientific Corp (BSX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):